The Dementia Screening Test (DST) is the only Dementia Test
which has been certified for Dementia Screening by Health Authorities.
More than 96 % sensitivity - probably the highest value for such tests worldwide.
(DST >96%, MMSE 81%) 6)
Reliably detects early stages -
proven in clinical studies.
Medical Device, CE marked -
certified by Health Authorities for Dementia Screening.
Includes progress monitoring and prevention recommendations.
Designed for home use.
No support person needed.
No prior knowledge needed.
Works on every current tablet or smartphone.
100 % anonymous - guaranteed!
No registration required.
No personal data collected.
No internet connection needed.
Awards & Recognitions
FAQ - Frequently Asked Questions
Who should perform the DST - Dementia Screening Test?
All persons latest at the age of 50 or older.
Who should not perform the DST - Dementia Screening Test?
The DST should not be performed by
- persons who are not willing and/or able to change their living habbits, even when faced with a serious medical diagnosis.
- persons who would over-react to a not completely impossible false positive result, if it has to be assumed that the over-reaction would cause more harm than an early intervention would cause benefit.
Which advantages does the DST - Dementia Screening Test have? Why should anyone take the test?
The DST benefits
1. the individual patient through early detection and intervention in a disease state when this is still possible.
2. the General Practitioners and Neurologists by relieving the daily routine in the practice, by targeting (only) those patients who are likely to benefit from further diagnostics.
3. society as a whole through early interventions, most of which are low cost / free of charge, and which delay or prevent high follow-up costs for many patients, e.g. by delaying / preventing a retirement home stay.
1) World Health Organization, https://www.who.int/features/factfiles/dementia/en/
2) Bradford et al (01 Oct 2009). "Missed and Delayed Diagnosis of Dementia in Primary Care: Prevalence and Contributing Factors". Alzheimer Disease Assoc Disord. 23(4):306-314. doi: 10.1097/WAD.0b013e3181a6bebc
3) Evans et al (08 Sep 2015). "Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia". Neurology. 85 (10): 898–904. doi:10.1212/WNL.0000000000001774.
4) Thyrian et al (April 2016). "Systematic, early identification of dementia and dementia care management are highly appreciated by general physicians in primary care – results within a cluster-randomized-controlled trial (DelpHi)". Journal of Multidisciplinary Healthcare: 183. doi:10.2147/JMDH.S96055.
5) Erde et al (Apr 1988). "On truth telling and the diagnosis of Alzheimer's disease". J Fam Pract. 26(4):401-6. PMID: 3356973
6) Tsoi et al. (01 Sep 2015). "Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis". JAMA Internal Medicine. 175 (9): 1450. doi:10.1001/jamainternmed.2015.2152.
8) World Health Organization: Risk reduction of cognitive decline and dementia. WHO Guideline